Anti-(p34 protein) antibodies inhibit ribosome binding to and protein translocation across the rough microsomal membrane  by Ichimura, Tohru et al.
Volume 326, number 1,2,3, 241-245 FEBS 12696 
© 1993 Federation ofEuropean Biochemical Societies 00145793193l$6.00 
July 1993 
Anti-(p34 protein) antibodies inhibit ribosome binding to and protein 
translocation across the rough microsomal membrane 
Tohru Ichimura , Yukiko Shindo b, Yasuyo Uda  b, Tomoya Ohsumi a, Saburo Omata b and Hiroshi 
Sugano a,* 
aDepartment ofBiosystem Science, Graduate School of Science and Technology and bDepartment ofBiochemistry, Faculty of Science, 
Niigata University, 2-1garashi, Niigata 950-21, Japan 
Received 12 April 1993; revised version received 24 May 1993 
The p34 protein is a non-glycosylated, integral membrane protein characteristic of rough microsomes and is believed to play a role in the 
ribosome-membrane ssociation. Here, antibodies directed against p34 were examined as to their inhibitory effect on ribosome binding to and 
protein translocation across the microsomal membrane. Preincubation of the stripped (ribosome-depleted) membrane with anti-p34 immunoglob- 
ulins (IgGs) or their Fab fragments led to more than 80% inhibition of the binding of ribosomes and their large (60S) subunit o the membrane. 
The inhibition was dependent on the amount of antibodies used, but comparable amounts of IgGs and Fab fragments from nonimmune serum 
had less effect. The p34 antibodies were also inhibitory for cotranslational translocation of secretory proteins, i.e. placental lactogen and serum 
albumin, across the membrane. These results uggest that p34 is involved in the binding of ribosomes to the microsomal membrane and that it 
is in close proximity to the protein translocation site in the microsomal membrane. 
Rough microsome; Ribosome-binding protein; Ribosome; Protein translocation; Rat; Liver 
1. INTRODUCTION 
The membranes of rough microsomes (RM) contain 
specific sites for binding with ribosomes ynthesizing 
secretory or membrane proteins. These binding sites are 
postulated to be functionally associated with a putative 
protein translocation channel in the membrane which 
facilitates the import of the synthesized proteins into the 
lumen of RM [1,2]. In vitro studies have revealed that 
the binding sites of RM comprise a protein(s) which is 
highly sensitive to trypsin [3 6]. The binding of ribo- 
somes to the trypsin-sensitive protein was shown to be 
salt-labile [3-6]. Recently, we isolated from rat liver RM 
a non-glycosylated, membrane protein with a relative 
molecular weight of 34 kDa (which we termed p34), and 
showed that it accounts for the majority of the ribo- 
some-binding activity in the membrane protein fraction 
which is recovered with ribosomes after solubilization 
of RM membranes with certain non-ionic detergents 
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[7,8]. The binding properties of this protein (e.g. trypsin- 
and salt-sensitivity) were also found to be similar to 
those of intact RM [8]. The p34 protein is localized 
specifically in ribosome-attached organelles (RM and 
nuclear envelope), and homologs of it are distributed 
widely among mammalian tissues [8]. However, al- 
though these data suggested the role of the p34 protein 
in the ribosome-membrane association, the physiologi- 
cal significance of this ribosome-binding protein has not 
yet been established. 
In this paper, evidence is presented that p34 is closely 
associated with the ribosome-binding/protein ra sloca- 
tion site in the RM membrane. It was found that incu- 
bation of the microsomal membrane with p34 antibod- 
ies abolished the capacity of the membrane for both 
ribosome binding and secretory protein translocation. 
2. EXPERIMENTAL 
2.1. Preparation and characterization f antibodies 
Rabbits (3 kg) were injected three times with -100/lg of p34 protein 
(in polyacrylamide gel) in Freund's adjuvant as described [8]. An 
immunoglobulin fraction was obtained from the serum by precipita- 
tion with ammonium sulfate. Fab fragments were prepared from IgG 
using an Fab preparation kit from Pierce. The specificity of the anti- 
bodies was confirmed by immunoblot analysis as described [8]. 
2.2. Inhibition of ribosome binding by antibodies 
Rat liver RM were treated with 0.5 mM puromycin/0.5 M KCI as 
described [4,9]. The stripped microsomes possessed a number of bind- 
ing sites, 65 nmol/g membrane proteins, as determined by the method 
of Yoshida et al. [9]. The stripped microsomes (20/~g protein) were 
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incubated with the indicated amounts of antibodies ( ee the legends 
to Figs. 1 and 2) for 5 h at 4°C in 100/11 of TKM buffer (50 mM 
Tris-HC1, pH 7.6, 100 mM KC1, 5 mM MgC12) containing a mixture 
of protease inhibitors (50 U/ml trasylol, and 0.5 mg/ml each of pep- 
statin, chymostatin, antipain and leupeptin). The process of antibody 
binding to the microsomal membrane was saturable under these con- 
ditions (not shown). 3H-Labeled ribosomes (1.4 #g RNA) or their 60S 
subunit (1 #g RNA) were then added, and incubation was continued 
for 10 rain at 4°C. The samples were each layered on a sucrose 
gradient (a linear 0.5 ~1 M sucrose gradient in TKM buffer (4.1 ml) on 
top of 0.8 ml of 2 M sucrose in the same buffer), followed by centrif- 
ugation for 50 min at 100,000 x g. The gradients were collected as 15 
equal fractions and a pellet fraction. Radioactivity was determined 
with an Aloka LSC-903 scintillation counter (Aloka Co. Ltd., Tokyo). 
2.3. Inhibition of translocation by antibodies 
For each assay, IgG fractions and monovalent Fab fragments were 
all prepared in PBS (10 mM phosphate, 145 mM NaCI, pH 7.2). The 
antibody preparation was mixed with a mixture of protease inhibitors 
(see above) in a total volume of 100#1 and then incubated at 22°C for 
15 rain. Rat liver rough microsomes (20 #g protein), which had previ- 
ously been stripped with sodium pyrophosphate [10], were then added, 
and incubation was continued with gentle shaking for 30 min at 22 ° C, 
followed by 30 min at 4°C. The microsomes were recovered by centrif- 
ugation for 30 min at 4°C in a microfuge, rinsed once with PBS, and 
then resuspended in 20 ,ul of 50 mM HEPES (pH 7.5) and 250 mM 
sucrose. In vitro translation/translocation reactions contained, in 25 
#1:10 #1 membrane suspension, 10 #1 rabbit reticulocyte lysate (Amer- 
sham Corp., code N.90Y), 0.25 #g messenger RNA, 5 #Ci 
[35S]methionine (Amersham Corp.), 60 mM KCI, 1.2 mM MgCI2, 
1 mM ATP, 0.2 mM GTP, 600 U/ml placental RNase inhibitor and 
the above protease inhibitors. After 60 rain at 30°C, the reactions were 
transferred to ice, and aliquots (12.5 #1) were treated with 50 #g/ml 
each of trypsin and chymotrypsin for 60 min at 0°C. To stop prote- 
olysis, 1,500 U/ml Trasylol was added for 15 min at 0°C. Proteins were 
precipitated with cold acetone (-20°C), and analyzed by SDS/ 12% 
polyacrylamide g l electrophoresis and subsequent fluorography [11]. 
2.4. Others 
3H-Labeled ribosomes and their 60S subunit were prepared as de- 
scribed [7,9]. The specific activities of the preparations were 1902 and 
1659 dpm/pg RNA, respectively. Messenger RNAs for hPL and RSA 
were isolated from human term placenta nd rat liver, respectively 
[I 1]. Protein concentrations were determined by the method of Lowry 
et al. [12], with bovine serum albumin as a standard. The concentra- 
tions of RNA were determined using Al~m = 265 at 260 nm [13]. The 
concentrations of ribosomes and the 60S subunit were calculated by 
assuming that they contain 52% RNA, and that M~ is 4.5 x 106 for 
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Fig. 1. Antibodies against the p34 protein inhibit ribosome binding to the stripped RM membrane. (A) Each binding mixture, comprising stripped 
RM (20 #g protein) that had been incubated in TKM buffer with p34-IgG (0.7 (c) and 1.8 (d) mg) or n-IgG (0.7 (e) and 1.8 (f) mg), and 1.4 #g 
of RNA of 3H-labeled ribosomes in 100 #1 of TKM buffer, was centrifuged through asucrose gradient (100,000 x g, 50 min), and then the resulting 
distribution of ribosomes was determined. As controls, the sedimentation f ribosomes in the absence (a) and presence (b) of stripped membranes 
is also shown. The direction of sedimentation was from right to left. Arrows indicate the position of the complex between the membrane and 
ribosomes. The recovery of total radioactivity was 68-83%. (B) Stripped RM (20/.tg protein) were preincubated with various amounts of p34-IgG 
or n-IgG (0.7, 1.3 and 1.8 mg), and then analyzed as to the binding activity toward ribosomes or the 60S subunit as in (A). The binding activity 
was calculated from the ratio of the radioactivity of ribosomes ( olid line) or the 60S subunit (dotted line) bound to the membrane against the total 
radioactivity recovered, and expressed as a percentage of the binding activity observed without antibody treatment closed circle, p34-IgG; open 
circle, n-IgG. 
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Fig. 2. Monovalent Fab fragments of p34-IgG inhibit ribosome re- 
binding. Stripped RM (20/lg protein) were preincubated with various 
amounts of Fab fragments of p34-IgG (closed circle) or n-IgG (open 
circle) (0.5, 1.1, 2.2 and 3.3 mg), and then analyzed as to their ribo- 
some-binding activity as in Fig. 1. 
3. RESULTS 
Previous studies revealed that the stripped micro- 
somal membrane possesses the capacity of re-binding 
an equivalent amount of ribosomes to that on the intact 
RM membrane [4,15,16]. Therefore, we first examined 
the effect of p34 antibodies on this process of rebinding 
of ribosomes to the stripped membrane. The stripped 
membrane was preincubated with IgGs produced from 
either antiserum or non-immune serum (termed p34- 
IgGs and n-IgGs, respectively), and then their ribo- 
some-binding capacity was determined using 3H-labeled 
ribosomes. As shown in Fig. 1A(c and d), incubation 
with p34-IgGs decreased the capacity of stripped mem- 
brane to rebind ribosomes. On the other hand, incuba- 
tion with n-IgGs had no effect (Fig. 1A(e and f)). The 
inhibitory effect observed was dependent on the amount 
of antibodies used, and more than 90% of the capacity 
to bind ribosomes was lost (Fig. 1 B, solid line). Preincu- 
bation with p34-IgG was also inhibitory toward the 
binding of the large (60S) ribosomal subunit, which is 
an essential subunit for ribosome attachment to the 
membrane. The observed inhibition was very similar to 
in the case of ribosomes (Fig. 1B, dotted line). 
We also examined the effect of monovalent Fab frag- 
ments to determine whether the observed inhibition was 
caused by cross-linking to p34 proteins on the stripped 
membrane. The Fab fragments produced from the p34- 
IgG fraction caused, like in the case of p34-IgGs, 
marked inhibition of ribosome re-binding (Fig. 2). 
Thus, the inhibition does not seem to be the conse- 
quence of cross-linking of p34 proteins through divalent 
antibodies. The Fab fragments from the n-IgG fraction 
were also inhibitory (up to 30%) with the use of 3.3 mg 
protein, but the effect was much lower than in the case 
of anti-p34 Fab fragments (Fig. 2). 
The ribosome-binding site is postulated to be func- 
tionally associated with the site of translocation. We 
assumed, therefore, that, if the effect of p34 antibodies 
is physiologically important, the antibodies might in- 
hibit the capacity of RM membranes to translocate se- 
cretory proteins. To test this assumption, a transloca- 
tion assay was performed (Fig. 3). As expected, preincu- 
bation of the microsomal membrane with p34-IgGs 
caused inhibition of the translocation of human placen- 
tal lactogen (hPL) (Fig. 3A, lanes 3 and 4, and 3" and 
4'). On the other hand, under the same conditions com- 
parable amounts of n-IgG had less effect (lanes 5 and 
6, and 5' and 6'). The p34-IgGs also inhibited the 
translocation of another secretory protein, rat serum 
albumin (Fig. 3B, lanes 2 and 2'). The translocation 
capacity of the microsomal membrane was unimpaired, 
however, when a translocation assay was performed 
using microsomes preincubated with p34-IgG fractions 
from which antibodies had been removed by adsorption 
to protein A-Sepharose. This suggests that the inhibi- 
tion was indeed caused by the antibodies and not by a 
contaminating agent in the immunoglobulin fraction 
(data not shown). Fig. 3C (lanes 3 and 4, and 3' and 4') 
demonstrates that the Fab fragments from p34-IgGs 
also inhibited the translocation of hPL. Thus, the inhi- 
bition is essentially due to the binding of the antibodies 
to the p34 protein. 
4. DISCUSSION 
The present study demonstrates the antibody-medi- 
ated inhibition of ribosome binding to and protein 
translocation across the microsomal membrane. Since 
p34 constitutes 1 + 0.2% of the total protein in the RM 
membrane, as determined by quantitative immunoblot- 
ting [17], and immunoglobulins as well as their Fab 
fragments should only cover a very small fraction of the 
membrane surface, the observed inhibition by antibod- 
ies (Figs. 1 and 2) appears to be due to masking of a 
specific site in the membrane that could facilitate in vivo 
association with ribosomes. Previous reconstitution 
studies [7,8] showed that the p34 protein accounts for 
the major ribosome-binding activity in an detergent ex- 
tract of the membrane, and that its ribosome-binding 
properties, including protease- and salt-sensitivity, are 
very similar to those of ribosome binding to stripped 
RM. Considering these facts, the present results uggest 
the possibility that the p34 protein directly participates 
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Fig. 3. Antibodies against p34 inhibit ranslocation. (A,B) Stripped microsomes (20 #g protein) were incubated with the indicated amounts of 
p34-IgGs or n-IgGs, and subsequently sedimented and resuspended. These microsomes were examined for the translocation f hPL (A) or BSA 
(B) in a cell-free system (see section 2). To determine translocation, half of each sample was treated with 50 #g/ml each of trypsin and chymotrypsin 
for 60 min at 0°C. (C) The translocation assay, using hPL, was carried out as in (A) except that Fab fragments were used instead of IgGs. phPL, 
pre-human placental lactogen. 
in the observed ribosome-membrane association [3 
6,15,16]. However, one cannot exclude another possibil- 
ity that other ribosome receptors exist in close proxim- 
ity to p34 in the membrane and thus that the inhibition 
by p34 antibodies toward other receptors could be indi- 
rectly caused by steric hindrance due to antibodies 
bound to p34. In any case, the inhibition of protein 
translocation by p34 antibodies observed here suggests 
that the p34 protein could be located in the proximity 
of the translocation site in the microsomal membrane. 
Beside the p34 protein, two RM membrane proteins 
with a relative molecular weights of 180 kDa [18] and 
40 kDa [19] have so far been shown to be ribosome 
receptors. Antibodies to one of these, the 180 kDa pro- 
tein, were recently demonstrated, like in the case of p34 
antibodies, to inhibit both ribosome binding and secre- 
tory protein translocation [20]. Immunodepletion f the 
p34 protein from the stripped membrane, followed by 
quantitation of the ribosome-binding activity and of 
protein translocation after reconstitution of this prepa- 
ration into liposomes will help clarify whether p34 is a 
component of the translocation apparatus that plays an 
essential role in ribosome binding and protein translo- 
cation in the microsomal membrane. Studies along 
these lines are currently in progress. 
Recent studies have indicated that the turning on/off 
of ribosomes on the microsomal membrane (ribosomal 
cycle) regulates protein translocation across the mem- 
brane. Simon and Blobel [2] demonstrated, by means of 
an electrophysiological technique, that the protein-con- 
ducting channel opens when ribosomes are attached to 
the membrane and closes when ribosomes become de- 
tached from the membrane. From this viewpoint, our 
results concerning the p34 protein may comprise further 
evidence that the r ibosome-membrane association is 
essential for protein import into the lumen of RM. 
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However, whether or not the ribosome-binding activity 
of the p34 protein is really involved in the regulation of 
the activity of the protein-conducting channel remains 
unknown. 
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